Jacob L. van Dam

1 ta ish

Erasmus MC Cancer Institute

1. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

   Eva Versteijne, Jacob L. van Dam, Mustafa Suker +30

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.466634